Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
NGEN
Stock Latest News
Company Announcements
NervGen Pharma Names New CFO and Wins Shareholder Backing for 2026 Equity Plan
4d ago
6K
NGEN
Premium
The Fly
NervGen Pharma appoints Keith Vendola as CFO
4d ago
NGEN
Premium
The Fly
NervGen Pharma initiated with a Buy at H.C. Wainwright
4d ago
NGEN
Premium
The Fly
NervGen Pharma initiated with a Buy at Lucid Capital
16d ago
NGEN
Premium
The Fly
NervGen Pharma price target raised to $12 from $10 at Maxim
23d ago
NGEN
Premium
Company Announcements
NervGen Wins FDA Alignment for Phase 3 RESTORE Trial in Chronic Tetraplegia
24d ago
NGEN
Premium
The Fly
NervGen Pharma aligns with FDA on RESTORE study following End-of-Phase 2 meeting
24d ago
NGEN
Premium
The Fly
NervGen Pharma price target lowered to $5.50 from $6.75 at Stifel
25d ago
NGEN
Premium
Ratings
NervGen Pharma: Buy Rating on De‑Risked Path to Pivotal NVG-291 Trials and Compelling Risk‑Reward in Chronic Spinal Cord Injury
30d ago
NGEN
Premium
Company Announcements
NervGen Maps Path to Phase 3 as NVG-291 Data Strengthen Neuroreparative Ambitions
1M ago
NGEN
Premium
Company Announcements
NervGen Pharma to Delist from TSX Venture Exchange, Keep Nasdaq Listing as NVG-291 Advances
2M ago
NGEN
Premium
The Fly
NervGen Pharma to delist shares from TSX
2M ago
NGEN
Premium
The Fly
NervGen Pharma price target raised to C$6.75 from C$5 at Stifel
2M ago
NGEN
Premium
The Fly
Nanogen appoints Ruff as Chief Regulatory Affairs Officer, McSherry as SVP
2M ago
NGEN
STOK
Premium
Company Announcements
NervGen Pharma CFO to Retire as Company Advances Late-Stage SCI Program
3M ago
NGEN
Premium
Company Announcements
NervGen Pharma Confirms Adam Rogers as CEO With New Equity-Rich Employment Deal
3M ago
6K
NGEN
Premium
Company Announcements
NervGen Pharma Confirms Adam Rogers as CEO to Steer Next Growth Phase
3M ago
NGEN
Premium
Company Announcements
NervGen Pharma Names Adam Rogers Permanent CEO to Drive Next Growth Phase
3M ago
NGEN
Premium
The Fly
Nanogen names Adam Rogers as president and CEO, effective immediately
3M ago
NGEN
Premium
The Fly
Ten new option listings and two option delistings on January 22nd
3M ago
AVR
INR
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
